跳至主要内容
临床试验/NCT04261829
NCT04261829招募中不适用

Autologous Fat Transfer: Introduction of a Full Breast Reconstructive Method

Maastricht University Medical Center8 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2020年12月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
350
试验地点
8
主要终点
Breast-related Quality of life

研究概览

简要总结

A multicentre prospective cohort study will monitor the efficacy and safety of Autologous Fat Transfer (AFT) with pre-expansion. AFT will be evaluated in terms of quality of life, aesthetic result, complications, oncological safety and cost-effectiveness. It follows the BREAST trial, the randomised controlled trial comparing AFT with implant-based reconstruction. In this study, patients all receive AFT.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female gender
  • Age of 18 years and older
  • History or in candidate for a mastectomy procedure in the near future
  • Patients undergoing preventive mastectomy
  • Patients' choice to undergo a breast reconstruction
  • Wanting to participate in this study
  • Patient is able to wear the external expansion device

排除标准

  • Active smoker or a history of smoking 4 weeks prior to surgery
  • Current substance abuse
  • History of lidocaine allergy
  • History of silicone allergy
  • 4 weeks or less after chemotherapy
  • History of radiation therapy in the breast region
  • Oncological treatment includes radiotherapy after mastectomy
  • Kidney disease
  • Steroid dependent asthma (daily or weekly) or other diseases
  • Immune-suppressed or compromised disease
  • Uncontrolled diabetes
  • Large breast size (i.e. larger than cup C), unless the patient prefers reduction of the contralateral side towards Cup C
  • Extra-capsular silicone leaking from the encapsulated implant from a previous breast reconstruction
  • The treating plastic surgeon has strong doubts on the patient's treatment compliance

结局指标

主要结局

Breast-related Quality of life

时间窗: 2 years

Measured by the BREAST-Q questionnaire (quality of life subdivision)

次要结局

  • Oncological safety(5 years)
  • Cost-effectiveness(2 years)
  • Aesthetic result(2 years)
  • Complications(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验